 GAITHERSBURG, Md., Oct. 25, 2021 GLOBE NEWSWIRE -- MaxCyte, Inc., NASDAQ: MXCT; LSE: MXCT, MXCN, a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization, today announced that it will release financial results for the third quarter of 2021 after the U.S. market close on Wednesday, November 10th, 2021. Company management will host a conference call to discuss financial results at 4:30 p.m. Eastern Time. 